Kibo Energy PLC Kibo Subsidiary MED Issue of Shares (3870A)

TIDMKIBO

RNS Number : 3870A

Kibo Energy PLC

23 May 2023

Kibo Energy PLC (Incorporated in Ireland)

(Registration Number: 451931)

(External registration number: 2011/007371/10)

LEI Code: 635400WTCRIZB6TVGZ23

Share code on the JSE Limited: KBO

Share code on the AIM: KIBO

ISIN: IE00B97C0C31

('Kibo' or 'the Company')

Dated: 23 May 2023

Kibo Energy PLC ('Kibo' or the 'Company')

Kibo Subsidiary Issue of Shares

Kibo Energy PLC (AIM: KIBO; AltX: KBO), the renewable energy focused development company, announces today that its subsidiary Mast Energy Developments ('MED'), a UK-based multi-asset operator in the rapidly growing flexible power market, has allotted 3,088,024 new MED shares of GBP0.001 each ('the 'Conversion Shares'), following receipt of a conversion notice from the institutional lender group under the terms of the recent reprofiling agreement (the 'Reprofiling Agreement') on the balance of MED's outstanding loan facilities as announced in an MED RNS dated 18 May 2023.

Application for the Conversion Shares will be admitted to the Standard List of the Official List and for trading on the main market of the London Stock Exchange PLC ('LSE'). The expected admission will become effective and dealings in the fee shares will commence at 08h00 on or around 30 May 2023.

The full announcement can be viewed at med.energy. The full text of the MED RNS follows:

______________________________________________________________________________

Dated: 23 May 2023

Mast Energy Developments PLC ('MED' or 'the Company')

Shares issue

Mast Energy Developments PLC, the UK-based multi-asset owner, developer, and operator in the rapidly growing flexible power market has today allotted 3,088,024 new MED shares of GBP0.001 each (the "Conversion Shares") following receipt of a conversion notice from the institutional lender group under the terms of the recent reprofiling agreement (the "Reprofiling Agreement") on the balance of its outstanding loan facilities announced on its RNS of 18 May 2023.

The shares are being issued in respect of GBP22,408.86 in principal payment at an exercise price of GBP0.0072567 per Conversion Share in accordance with the terms of the Reprofiling Agreement.

Application will be made for the Conversion Shares to be admitted to the Standard List segment of the Official List and to trading on the main market of the London Stock Exchange plc ("Admission"). It is expected that Admission will become effective and dealings in the Fee Shares will commence at 8.00am on, or around, 30 May 2023.

Following Admission, the total issued share capital of the Company will consist of 232,207,643 ordinary shares in issue and this figure may be used by shareholders as the denominator for the calculations to determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

ENDS

This announcement contains inside information for the purposes of the UK version of the Market Abuse Regulation (EU No. 596/2014) as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 ('UK MAR'). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

For further information please visit www.med.energy or contact:

 
 Pieter Krügel   [e-mail]                 Mast Energy Developments   CEO 
                                                       PLC 
                     ------------------------------  -------------------------  ----------------- 
 Jon Belliss          [phone]             Novum Securities           Corporate 
                                                                                  Broker 
-------------------  ------------------------------  -------------------------  ----------------- 
 Zainab Slemang       [e-mail]   Lifa Communications        Investor & 
  van Rijmenant                                                                   Media Relations 
                                                                                  Advisor 
-------------------  ------------------------------  -------------------------  ----------------- 
 

____________________________________________________________________________

This announcement contains inside information for the purposes of the UK version of the Market Abuse Regulation (EU No. 596/2014) as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 ('UK MAR'). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

**ENDS**

For further information please visit www.kibo.energy or contact:

 
 Louis Coetzee     [e-mail]                Kibo Energy PLC          Chief Executive 
                                                                             Officer 
 James Biddle      [phone]                Beaumont Cornish         Nominated Adviser 
  Roland Cormish                                    Limited 
                  ------------------------------  -----------------------  ---------------------- 
 Claire Noyce      [phone]                Hybridan LLP             Joint Broker 
                  ------------------------------  -----------------------  ---------------------- 
 Damon Heath       [phone]                Shard Capital Partners   Joint Broker 
                                                    LLP 
                  ------------------------------  -----------------------  ---------------------- 
 Zainab Slemang    [e-mail]   Lifa Communications      Investor and Media 
  van Rijmenant                                                              Relations Consultant 
                  ------------------------------  -----------------------  ---------------------- 
 

Johannesburg

23 May 2023

Corporate and Designated Adviser

River Group

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCAJMJTMTMTBAJ

(END) Dow Jones Newswires

May 23, 2023 09:30 ET (13:30 GMT)